Skip to main content
Clinical Trials/ITMCTR2000003033
ITMCTR2000003033Not yet recruitingPhase 1

A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 60 (—)
Sex
All

Inclusion Criteria

  • 1. Aged 18 to 60 years old;
  • 2. Inpatients who meet the diagnostic criteria for mild, general and neonatal pneumonia in western medicine, and early and recovery stages of traditional Chinese medicine;
  • 3. Understand and agree to participate in this study and sign the informed consent.

Exclusion Criteria

  • 1. Patients with other serious diseases such as lung diseases, cardiovascular and cerebrovascular diseases, hematopoietic diseases, autoimmune diseases, digestive system, or mental illness;
  • 2. Pregnant or lactating women;
  • 3. Participate in other forms of exercise during the trial

Investigators

Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,

Similar Trials